Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,354 GBp
Change Today +5.50 / 0.41%
Volume 643.0K
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 3:57 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Dunoyer

Former Global Head of Rare Diseases and Chairman of GSK Japan, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
631,921,000 GBP

Background*

Mr. Marc Dunover has been the Chief Financial Officer of AstraZeneca PLC since November 1, 2013. Mr. Dunover served as Executive Vice President of Global Portfolio & Product Strategy at AstraZeneca PLC from June 2013 to October 2013. He served as the Global Head of Rare Diseases Unit of JCR Pharmaceuticals Co., Ltd. He served as Head of Rare Diseases Unit at GlaxoSmithKline since February 2010. He served as President of Asia Pacific/Japan at GlaxoSmithKline plc until ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Chairman
2010-N/A
Former Global Head of Rare Diseases Unit and Executive Director
2013-Present
Chief Financial Officer and Executive Director

Education*

MBA
Ecole des Hautes Etudes Commerciales de Montreal
LLB
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

Salary680,000 GBP
Bonus1,016,000 GBP
Total Annual Compensation1,696,000 GBP

Stock Options*

All Other Compensation225,000 GBP

Total Compensation*

Total Annual Cash Compensation1,921,000 GBP
Total Short Term Compensation1,696,000 GBP
Other Long Term Compensation225,000 GBP
Total Calculated Compensation1,921,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,354.00 GBp +5.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Kurt W. Bock Chairman of The Board of Executive Directors and Chief Executive Officer
BASF SE
€3.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.